Formulate Labs, Inc.

New Filing

CIK: 0001827318·Other·DELAWARE·Filed: Jul 10, 2025

Total Offering

$6,890,983

Amount Sold

$1,393,516

Investors

21

First Sale

Jun 27, 2025

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Osmaan Shah	Related Person
Michael Savino	Related Person

Company

Formulate Labs, Inc.

1645 Headland Dr.

Fenton, MO, 63026

312-283-4854

SEC Filing

0001827318-25-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.